AU2006203499B2 - Method and apparatus for improving mitral valve function - Google Patents

Method and apparatus for improving mitral valve function Download PDF

Info

Publication number
AU2006203499B2
AU2006203499B2 AU2006203499A AU2006203499A AU2006203499B2 AU 2006203499 B2 AU2006203499 B2 AU 2006203499B2 AU 2006203499 A AU2006203499 A AU 2006203499A AU 2006203499 A AU2006203499 A AU 2006203499A AU 2006203499 B2 AU2006203499 B2 AU 2006203499B2
Authority
AU
Australia
Prior art keywords
coronary sinus
posterior
mitral valve
leaflet
anteriorly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2006203499A
Other versions
AU2006203499A1 (en
Inventor
William E. Cohn
Todd F. Davenport
John R. Liddicoat
Richard B. Streeter
Daniel C. Taylor
Steven B. Woolfson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Viacor Inc
Original Assignee
Viacor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2002240288A external-priority patent/AU2002240288B2/en
Application filed by Viacor Inc filed Critical Viacor Inc
Priority to AU2006203499A priority Critical patent/AU2006203499B2/en
Publication of AU2006203499A1 publication Critical patent/AU2006203499A1/en
Application granted granted Critical
Publication of AU2006203499B2 publication Critical patent/AU2006203499B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2451Inserts in the coronary sinus for correcting the valve shape

Landscapes

  • Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Prostheses (AREA)

Description

Regulation 3.2
AUSTRALIA
Patents Act 1990 COMPLETE SPECIFICATION DIVISIONAL APPLICATION
APPLICANT:
Invention Title: VIACOR, INC.
METHOD AND APPARATUS FOR IMPROVING MITRAL VALVE FUNCTION The following statement is a full description of this invention, including the best method of performing it known to me:
\O
IND
J METHOD AND APPARATUS FOR IMPROVING MITRAL VALVE FUNCTION Reference To Pending Prior Patent Applications S 5 This patent application claims benefit of: 0 pending prior U.S. Provisional Patent
(N
NO Application Serial No, 60/266,766, filed 02/05/01 by C- William E. Cohn et al. for TRANSVASCULAR APPROACH TO MITRAL VALVE PROCEDURES (Attorney's Docket No. VIA-16
PROV);
pending prior U.S. Provisional Patent Application Serial No. 60/273,893, filed 03/05/01 by William E. Cohn et al. for TRANSVASCULAR METHODS AND DEVICES FOR MITRAL VALVE PROCEDURES (Attorney's Docket No. VIA-17 PROV); pending prior U.S. Provisional Patent Application Serial No. 60/278,153, filed 03/23/01 by William E. Cohn et al. for METHOD AND APPPARATUS TO IMPROVE MITRAL VALVE FUNCTION (Attorney's Docket No.
VIA-18 PROV); 0 2pending prior U.S. Provisional Patent Application Serial No. 60/279,974, filed 03/29/01 by Daniel C. Taylor et al. for METHOD AND APPARATUS TO IMPROVE MITRAL VALVE FUNCTION (Attorney's Docket No.
ft 5 VIA-19 PROV); C, pending prior U.S. Provisional Patent O Application Serial No. 60/280,038, filed 03/30/01 by William E. Cohn et al. for METHODS AND APPARATUS FOR TEMPORARY IMPROVEMENT IN MITRAL VALVE FUNCTION (Attorney's Docket No. VIA-20 PROV); pending prior U.S. Provisional Patent Application Serial No. 60/279,973, filed 03/29/01 by Daniel C. Taylor et al. for METHODS AND DEVICES TO IMPROVE MITRAL VALVE FUNCTION (Attorney's Docket No.
VIA-21 PROV); pending prior U.S. Provisional Patent Application Serial No. 60/283,820, filed 04/13/01 by William E. Cohn et al. for METHOD AND APPARATUS FOR TEMPORARY IMPROVEMENT IN MITRAL VALVE FUNCTION (Attorney's Docket No. VIA-22 PROV); 3 pending prior U.S. Provisional Patent Application Serial No. 60/312,217, filed 08/14/01 by Daniel C. Taylor et al. for METHOD AND APPARATUS FOR TEMPORARY IMPROVEMENT IN MITRAL VALVE FUNCTION (Attorney's Docket No. VIA-23 PROV); pending prior U.S. Provisional Patent Application Serial No. 60/339,481, filed 10/26/01 by William E. Cohn et al. for TRANSVASCULAR APPROACH TO MITRAL VALVE PROCEDURES (Attorney's Docket No.
VIA-30 PROV); and pending prior U.S. Provisional Patent Application Serial No. 60/348,424, filed 01/14/02 by Daniel C. Taylor et al. for METHOD AND APPARATUS TO IMPROVE MITRAL VALVE FUNCTION (Attorney's Docket No.
VIA-31 PROV).
The aforementioned ten (10) patent applications are hereby incorporated herein by reference.
Field Of The Invention This invention relates to surgical methods and apparatus in general,,and more particularly to 4 surgical methods and apparatus for improving mitral valve function.
Background Of The Invention Mitral valve repair is the procedure of choice to correct mitral regurgitation of all etiologies. With the use of current surgical techniques, between and 95% of regurgitant mitral valves can be repaired.
The advantages of mitral valve repair over mitral valve replacement are well documented. These include better preservation of cardiac function and reduced risk of anticoagulant-related hemorrhage, thromboembolism and endocarditis.
In.current practice, mitral valve surgery requires an extremely invasive approach that includes a chest wall incision, cardiopulmonary bypass, cardiac and pulmonary arrest, and an incision on the heart itself to gain access to the mitral valve. Such a procedure is associated with high morbidity and mortality. Due to the risk associated with this procedure, many of the sickest patients are denied the 5 potential benefits of surgical correction of mitral regurgitation. In addition, patients with moderate, symptomatic mitral regurgitation are denied early intervention and undergo surgical correction only after the development of cardiac dysfunction.
Mitral regurgitation is a common occurrence in patients with heart failure and a source of important morbidity and mortality in these patients. Mitral regurgitation in patients with heart failure is caused by changes in the geometric configurations of the left ventricle, papillary muscles and mitral annulus.
These geometric alterations result in incomplete coaptation of the mitral leaflets at systole. In this situation, mitral regurgitation is corrected by plicating the mitral valve annulus, either by sutures alone or by sutures in combination with a support ring, so as to reduce the circumference of the distended annulus and restore the original geometry of the mitral valve annulus.
More particularly, current surgical practice for mitral valve repair generally requires that the mitral 6 valve annulus be reduced in radius by surgically opening the left atrium and then fixing sutures, or more commonly sutures in combination with a support ring, to the internal surface of the annulus; this structure is used to cinch the annulus, in a pursestring-like fashion, to a smaller radius, thereby reducing mitral regurgitation by improving leaflet coaptation.
This method of mitral valve repair, generally termed "annuloplasty", effectively reduces mitral
L
regurgitation in heart failure patients. This, in turn, reduces symptoms of heart failure, improves quality of life and increases longetivity.
Unfortunately, however, the invasive nature of mitral valve surgery and the attendant risks render most heart failure patients poor surgical candidates.
Thus, a less invasive means to increase leaflet coaptation and thereby reduce mitral regurgitation in heart failure patienta would make this therapy available to a much greater percentage of patients.
7 Mitral regurgitation also occurs in approximately of patients suffering acute myocardial infarction.
In addition, mitral regurgitation is the primary cause of cardiogenic shock in approximately 10% of patients who develop severe hemodynamic instability in the setting of acute myocardial infarction. Patients with mitral regurgitation and cardiogenic shock have about a 50% hospital mortality. Elimination of mitral regurgitation in these patients would be of significant benefit. Unfortunately, however, patients with acute mitral regurgitation complicating acute myocardial infarction are particularly high-risk surgical candidates, and are therefore not good candidates for a traditional annuloplasty procedure.
Thus, a minimally invasive means to effect a temporary reduction or elimination of mitral regurgitation in these critically ill patients would afford them the time to recover from the myocardial infarction or other acute life-threatening events and make them better candidates for medical, interventional or surgical therapy.
Summary Of The Invention As a result, the present invention advantageously provides an improved method and apparatus for reducing mitral regurgitation.
The present invention also advantageously provides a method and apparatus for reducing mitral regurgitation which is minimally invasive.
Further the present invention advantageously provides a method and apparatus for reducing mitral regurgitation which can be deployed either permanently for patients suffering from heart failure) or temporarily for patients suffering from mitral regurgitation with acute myocardial infarction).
These and other advantages are addressed by the present invention, which comprises an improved method and apparatus for reducing mitral regurgitation.
In one form of the invention, there is provided a method for reducing mitral regurgitation comprising: inserting apparatus into the coronary sinus of a patient in the vicinity of the posterior leaflet of 9 the mitral valve, the:apparatus being adapted to straighten the natural curvature of at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
In another form of the invention, there is provided a method for reducing mitral regurgitation comprising: inserting apparatus into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the apparatus being adapted to move at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve anteriorly, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
In another form of the invention, there is provided a method for reducing mitral regurgitation comprising: inserting apparatus into the coronary sinus of a patient in the vicinity of the posterior leaflet of 10 the mitral valve, the apparatus being adapted to reduce the degree of natural curvature of at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
In another form of the invention, there is provided a method for reducing mitral regurgitation comprising: inserting apparatus into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the apparatus being adapted to increase the natural radius of curvature of at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
In another form of the invention, there is provided a method for reducing mitral regurgitation comprising: 11 inserting apparatus into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the apparatus having a distal end, a proximal end and an intermediate portion, the apparatus being configured so that when the apparatus is positioned in the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, the distal and proximal ends will apply a posteriorly-directed force to the walls of.the coronary sinus and the intermediate portion Will apply an anteriorly-directed force to the walls of the coronary sinus, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
In another form of the invention, there is provided a method for reducing mitral regurgitation comprising: inserting a substantially straight elongated body into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the length of the substantially straight elongated body being sized relative to the natural curvature of the 12 coronary sinus in the vicinity of the posterior leaflet of the mitral valve so that when the substantially straight elongated body is positioned in the coronary sinus, it will cause at least a portion of the coronary sinus to assume a substantially straight configuration adjacent to the posterior leaflet of the mitral valve, whereby.to increase the radius of curvature of the mitral annulus and thereby improve leaflet coaptation.
In another form of the invention, there is provided a method for reducing mitral regurgitation comprising: inserting a substantially rigid elongated body into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the substantially rigid elongated body being configured relative to the natural curvature of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve so that when the substantially rigid elongated body is positioned in the coronary sinus, it will cause at least a portion of the coronary sinus to 13 assume a different configuration adjacent to the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
In another form of the invention, there is provided a method for reducing mitral regurgitation comprising: inserting a straight, substantially rigid elongated body into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the length of the straight, substantially rigid elongated body being sized relative to the natural curvature of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve so that when the straight, substantially rigid elongated body is positioned in thecoronary sinus, it will cause at least a portion of the coronary sinus to assume a substantially straight configuration adjacent to the posterior leaflet of the mitral valve, whereby to increase the radius of curvature of the mitral annulus and thereby improve leaflet coaptation.
14 In another form of the invention, there is provided an apparatus for reducing mitral regurgitation comprising: a body having a distal end, a proximal end and an intermediate portion, the body being configured so that when the body is positioned in the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, the distal and proximal ends will apply a posteriorly-directed force to the walls of the coronary sinus, and the intermediate portion will apply an anteriorly-directed force to the walls of the coronary sinus, whereby to move the posterior annulus of the mitral valve anteriorly and thereby improve leaflet coaptation.
In another form of the invention, there is provided an apparatus -for reducing mitral regurgitation comprising: a substantially straight elongated body adapted to be inserted into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the length of the substantially straight elongated body being sized relative to the natural curvature of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve so that when the substantially straight elongated body is positioned in the coronary sinus, it will cause at least a portion of the coronary sinus to assume a substantially straight configuration adjacent to the posterior leaflet of the mitral valve, whereby to increase the radius of curvature of the mitral annulus, moving it anteriorly, and thereby improve leaflet coaptation.
In another form of the invention, there is provided an apparatus for reducing mitral regurgitation comprising: a substantially rigid elongated body adapted to be inserted into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the length of the straight, substantially rigid elongated body being sized relative to the natural curvature of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve so that when the substantially rigid elongated body is positioned in 16 the coronary sinus, ii will cause at least a portion of the coronary sinus, to assume a different configuration adjacent to the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
In another form of the invention, there is provided an apparatus for reducing mitral regurgitation comprising: a straight, substantially rigid elongated body adapted to be inserted into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the length of the straight, substantially rigid elongated body being sized relative to the natural curvature of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve so that when the straight, substantially rigid elongated body is positioned in the coronary sinus, it will cause at least a portion of the coronary sinus to assume a substantially straight configuration adjacent to the posterior leaflet of the mitral valve, whereby to increase the radius of 17 curvature of the mitral annulus, moving it anteriorly, and thereby improve leaflet coaptation.
Significantly, the present invention may be practiced in a minimally invasive manner, either permanently or temporarily, so as to reduce mitral regurgitation.
Brief Description Of The Drawings These and other objects and features of the present invention will be more fully disclosed or rendered obvious by the following detailed description of the preferred embodiments of the invention, which is to be considered together with the accompanying drawings wherein like numbers refer to like parts and further wherein: Fig. 1 is a schematic view of portions of the human vascular system; Fig. 2 is a schematic view of portions of the human heart; Fig. 3 is a schematic view of a preferred system formed in accordance with the present invention; 18 Figs. 4-7 are a series of views illustrating use of the system of Fig. 3 to reduce mitral regurgitation; Fig. 8 shows an alternative form of delivery catheter; Fig. 9 shows an alternative form of flexible push rod; Fig. 9A shows another alternative form of the present invention; Figs. 10 and 11 show alternative constructions for the straight, substantially rigid elongated body; Fig. 12 shows an alternative system formed in accordance with the present invention; and Fig. 13 shows use of the system shown in Fig. 12.
Detailed Description Of The Preferred Embodiments The coronary sinus is the largest vein in the human heart. During a large portion of its course in the atrioventricular groove, the coronary sinus typically extends adjacent to the left atrium of the heart for a distance of approximately 5 to 19 centimeters. Significantly, for a portion of its length, typically approximately 7-9 cm, the coronary sinus extends substantially adjacent to the posterior perimeter of the mitral annulus. The present invention takes advantage of this fact. More particularly, by deploying.novel apparatus in the coronary sinus, adjacent to the posterior leaflet of the mitral valve, the natural curvature of the coronary sinus may be modified in the vicinity of the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly so as to improve leaflet coaptation and, as a result, reduce mitral regurgitation.
In one preferred.embodiment of the invention, the -novel apparatus comprises a straight, substantially rigid elongated body, the length of the straight, substantially rigid elongated body being sized so that when the straight, substantially rigid body is positioned in the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, the straight, substantially rigid elongated body will 20 cause at least a portion of the coronary sinus to assume a substantially straight configuration adjacent to the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
And in one preferred embodiment of the invention, access to the coronary sinus is gained percutaneously, the straight, substantially rigid elongated body is introduced into the patient's vascular system via the jugular vein orvia the left subclavian vein, passed down the super+or vena cava, passed through the right atrium and then passed into the coronary sinus, where it is deployed. Alternatively, the straight, substantially rigid elongated body may be introduced into the coronary sinus through a small incision in the heart, or through some other incision into the patient's vascular system.
And in one preferred embodiment of the invention, the straight, substantially rigid elongated body is guided into position by passing it through a -21 pre-positioned catheter, or (ii) passing it over a pre-positioned guidewire, or (iii) passing it guide-free on the end of a steerable delivery tool) to the surgical site.
Once deployed, the novel apparatus may be left in position permanently in the case of patients suffering from mitral regurgitation associated with heart failure) or the novel apparatus may be left in position only temporarily in the case of patients suffering from mitral regurgitation associated with acute myocardial infarction).
Visualization of the procedure may be obtained by fluoroscopy, echocardiography, intravascular ultrasound, angioscopy, real-time magnetic resonance imaging, etc. The efficacy of the procedure may be determined through echocardiography, although other imaging modalities may also be suitable.
Looking now at Fig. 1, there are shown aspects of the cardiovascular system 3 of a patient. More particularly, cardiovascular system 3 generally comprises the heart 6, the superior vena cava 9, the 22 right subclavian vein 12, the left subclavian vein the jugular vein 18, and the inferior vena cava 21.
Superior vena cava 9 and inferior vena cava 21 communicate with the heart's right atrium 24. The coronary ostium 27 leads to coronary sinus 30. At the far end 31 (Fig. 2) of coronary sinus 30, the vascular structure turns into the vertically-descending anterior interventricular vein 32 (see Fig. For purposes of the present invention, it can generally be convenient to consider the term "coronary sinus" to mean the vascular structure extending between coronary ostium 27 and AIV 32.
As seen in Fig. 2, between coronary ostium 27 and AIV 32, coronary sinus 30 generally extends substantially adjacent to the posterior perimeter of the annulus 33 of the mitral valve 36. Mitral valve 36 comprises a posterior leaflet 39 and an anterior leaflet 42. In the case of a regurgitant mitral valve, posterior leaflet 39 and anterior leaflet 42 will generally fail to properly coapt at systole, 23 thereby leaving an intervening gap 45 which will permit regurgitation.
Looking next at Fig. 3, there is shown a system 100 which comprises one preferred embodiment of the present invention.: More particularly, system 100 generally comprises a guidewire 103, a delivery catheter 106 and a push rod 109.
Guidewire 103 comprises a flexible body 112 having a distal end 115 and a proximal end 118. The distal end 115 of guidewire 103 preferably includes a spring tip 121 for allowing the distal end of guidewire 106 to atraumatically traverse vascular structures, while the guidewire is being passed through the vascular system of a patient.
Delivery catheter 106 comprises a flexible body 124 having a distal end 127 and a proximal end 130, preferably with an adjustable valve 133 attached. A central lumen 136 extends from distal end 127 to proximal end 130. In some circumstances it may be desirable to provide a securing mechanism for securing the distal end of the delivery catheter within a 24 vascular structure. By way of example but not limitation, a balloon 139 may be positioned about the exterior of flexible body 124, just proximal to distal end 127, with an inflation lumen 142 extending between balloon 139 and an inflation fitting 145.
Push rod 109 comprises a flexible body 148 having a distal end 151 and a proximal end 154. A straight, substantially rigid elongated body 157, which may have a variety of different lengths, is formed on flexible body 148, proximal to distal end 151. A removable proximal stiffener or handle 160 may be placed between straight, substantially rigid elongated body 157 and proximal end 154.
System 100 may be used as follows to reduce mitral regurgitation.
First, distal end 115 of guidewire 103 is passed down the jugular vein 18 (or the left subclavian vein of a patient, down superior vena cava 9, through right atrium 24 of the heart, and then into coronary sinus 30. See Fig. 4. It will be appreciated that as flexible guidewire 103 is passed down coronary sinus 25 the guidewire will tend to assume the natural curved shape of the coronary sinus, due to the flexible nature of the guidewire. The guidewire's atraumatic spring tip 121 will help ensure minimal damage to vascular structures as guidewire 103 is maneuvered into position.
Next, distal end 127 of delivery catheter 106 is placed over proximal end 118 of guidewire 103 and passed down the guidewire until the distal end of the delivery catheter is positioned in coronary sinus See Fig. 5. Again, it will be appreciated that as the flexible delivery catheter 106 passes down the coronary sinus, the delivery catheter will tend to assume the natural curved shape of the coronary sinus, due to the flexible nature of the delivery catheter.
Once delivery catheter 106 has been positioned within the coronary sinus, guidewire 103 is removed.
See Fig. 6. Either before or after guidewire 103 is removed, balloon 139 1ay be inflated so as to secure distal end 127 of delivery catheter 106 in position within coronary sinus 26 Next, push rod 109 is passed down the central lumen 136 of delivery catheter 106. As the push rod's straight, substantially rigid elongated body 157 is passed down central lumen 136 of delivery catheter 106, it will force the delivery catheter to assume a straight configuration at the point where the straight, substantially rigid elongated body 157 currently resides; As push rod 109 is pushed down delivery catheter 106, balloon 139 will hold the distal end of the delivery catheter in position within coronary sinus Push rod 109 is pushed down delivery catheter 106, utilizing removable proximal stiffener 160 as needed, until the straight, substantially rigid elongated body 157 is'located adjacent to the posterior annulus of mitral valve 36. See Fig. 7. As this occurs, the presence of the straight, substantially rigid elongated body 157 in delivery catheter 106 will cause at least a portion of coronary sinus 30 to assume a substantially straight configuration at this point, so that the posterior 27 annulus of mitral valve 36 is forced anteriorly. This will cause the mitral valve's posterior leaflet 39 to also move anteriorly so as to improve mitral valve leaflet coaptation and thereby reduce (or completely eliminate) mitral valve regurgitation. In this respect it should be appreciated that the posterior annulus may be shifted anteriorly so as to achieve, or to attempt to achieve to the extent anatomically possible, leaflet-to-leaflet engagement or leaflet-to-annulus engagement where a leaflet may be tethered due to left ventricular distortion).
Both of these types of engagement, or targeted engagement, are intended to be encompassed by the terms "improved leaflet coaptation" and/or "increased leaflet coaptation" and the like. Using standard visualization means echocardiography or fluoroscopy), the exact position of the straight, substantially rigid elongated body 157 is adjusted so as to reduce (or completely eliminate) regurgitation in mitral valve 36.
28 In this respect it should be appreciated that the straight, substantially rigid elongated body 157 is preferably sized to be somewhat less than the length of the coronary sinus between coronary ostium 27 and AIV 32. However, in some circumstances it may be desirable to size the straight, substantially rigid ND elongated body 157 so that it will extend out of the C coronary sinus and into the right atrium.
Furthermore, it should also be appreciated that the system provides a degree of tactile feedback to the user during deployment. More particularly, substantial resistance will typically be encountered as the straight, substantially rigid elongated body 157 is pushed out of right atrium 24 and into coronary sinus 30; then resistance will typically drop as body 157 is moved through the coronary sinus; and then resistance will typicilly increase significantly again as the distal tip of body 157 comes to the far end 31 of the coronary sinus. Thus, there is a sort of tactile "sweet spot" when the straight, substantially rigid elongated body 157 is located in the coronary 29 sinus between coronary ostium 27 and AIV 32, and this tactile "sweet spot" can be helpful to the user in positioning the straight, substantially rigid elongated body 157 in coronary sinus At this point the straight, substantially rigid elongated body 157 is locked in position, by closing adjustable valve 133, and balloon 139 may be deflated.
System 100 is left in this position until it is no longer needed. In some cases this may mean that system 100 is left in position for a period of a few hours, days or weeks; in other cases system 100 may be substantially permanent. If and when system 100 is to
C
be removed, push rod 109 is removed from delivery catheter 106, and then delivery catheter 106 is removed from the patient.
Thus it will be seen that with the present invention, the straight, substantially rigid elongated body 157 is essentially force-fit into the normally curved portion of the coronary sinus adjacent to the mitral valve's posterior leaflet. By properly sizing 30 the length of the straight, substantially rigid elongated body 157 relative to the natural curvature of the patient's anatomy, and by properly positioning the straight, substantially rigid elongated body 157 in the patient's coronary sinus, the straight, substantially rigid elongated body will cause at least a portion of the coronary sinus to assume a substantially straight configuration adjacent to the posterior leaflet of the mitral valve. This action will in turn drive the posterior annulus of the mitral valve anteriorly, so as to improve leaflet coaptation and thereby reduce mitral regurgitation. Thus, by inserting the straight, substantially rigid elongated body 157 into the coronary sinus adjacent to the posterior leaflet of the mitral valve, the annulus of the mitral valve is effectively manipulated so that it will assume an increased radius of curvature.
It has also been found that by inserting the straight, substantially rigid elongated body into the coronary sinus adjacent to the posterior leaflet of the mitral valve, the left ventricle may also be 31 jo! remodeled so as to help alleviate congestive heart failure.
It is significant to note that with the present invention, the distal'and proximal ends of straight, substantially rigid elongated body 157 apply a posteriorly-directed force on the walls of coronary I sinus 30 as shown with arrows P in Fig. 7) C-i while the intermediate portion of straight, substantially rigid elongated body 157 applies an anteriorly-directed force on the walls of coronary sinus 30 as shown with arrows A in Fig. 7).
In some cases the proximal end 130 of delivery catheter 106 may be fixed to the patient's outer skin using standard patient care methods such as adhesive tape, pursestring sutures, skin staples, etc. In other cases proximal end 130 of delivery catheter 106 may include a sewing cuff whereby the delivery catheter may be secured to the patient's tissue by suturing. See, for example, Fig. 8, where a sewing cuff 166 is shown attached to the proximal end 130 of delivery catheter 106. If desired, an element 169 may 32 be provided proximal to adjustable valve 133, whereby flexible push rod 109%may be made fast to delivery catheter 106. By way.of example, element 169 may comprise a crimpable element to secure flexible push rod 109 to delivery catheter 106, which is in turn secured to the patient. If desired, the proximal end of the assembly may be embedded under the skin of the patient, in the case of a permanent implant.
As noted above, it can be helpful to anchor the distal end of delivery catheter 106 in position within the coronary sinus prior to pushing push rod 109 into the delivery catheter. Such an arrangement will keep the delivery catheter in place as the push rod makes the turn within the right atrium and enters the coronary sinus. In the absence of such anchoring, the push rod may drive the delivery catheter down the inferior vena cava 21. By securing the distal end of delivery catheter 106 to the walls of coronary sinus the delivery catheter can be stabilized against diversion down the inferior vena cava 21 when the straight, substantially rigid elongate body 157 33encounters initial resistance to making the turn into the coronary sinus.
The balloon 139 is one way of accomplishing such anchoring. However, it is also possible to utilize other types of securing mechanisms to anchor the distal end 127 of delivery catheter 106 in position within coronary sinus 30, spring clips, ribs, etc.
Alternatively, and looking next at Fig. 9, the distal end 151 of push rod 109 may itself be provided with a distal anchor, such as the distal anchor 172 shown in Fig. 9.
It is also possible to prevent diversion of delivery catheter 106 down inferior vena cava 21 without anchoring the distal end of delivery catheter 106 or flexible push rod 109 to the walls of the coronary sinus. More particularly, and looking now at Fig. 9A, there is shown a support catheter 173 which is formed out of a more rigid material than delivery catheter 106. Support catheter 173 is constructed so that its distal end 174 can be positioned in coronary 34 ostium 27 and then its sidewall 174A can support delivery catheter 106 adjacent to inferior vena cava 21 when push rod 109 is passed down delivery catheter 106, whereby to prevent delivery catheter 106 from diverting down inferior vena cava 106. Fig. 9A also shows an introducer catheter 174B at the entrance to jugular vein 18.
As noted above, as push rod 109 is advanced to the region adjacent to the posterior annulus of the mitral valve, the straight, substantially rigid elongated body 157 will distort the natural configuration of the coronary sinus so that it will assume a substantially straight configuration. While this action induces the desired valve remodeling, it can also induce a significant stress on the walls of the coronary sinus, particularly at the distal and proximal ends of the straight, substantially rigid elongated body 157, where stress will be concentrated.
To this end, the construction of the straight, substantially rigid elongated body 157 may be modified somewhat so as to better distribute this stress. More 35 particularly, and looking next at Fig. 10, the distal and proximal ends of straight, substantially rigid elongated body 157 may include relatively flexible portions 175 to help better distribute the stress exerted on the walls of the coronary sinus.
Additionally, and/or alternatively, any taper applied to the distal and proximal ends of straight, substantially rigid elongated body 157 may be elongated, such as shown at 178 in Fig. 11, so as to better distribute the stress imposed on the walls of the coronary sinus.
Looking next at Pig. 12, there is shown a system 181 which comprises another preferred embodiment of the present invention. More particularly, system 181 generally comprises the guidewire 103, a straight, substantially rigid elongated body 184 and a push cannula 187.
Guidewire 103 isas previously described.
Straight, substantially rigid elongated body 184, which may have a variety of different lengths, comprises a distal en- 188 and a proximal end 190. A 36 central lumen 193 extends between distal end 188 and proximal end 190. Central lumen 193 accommodates guidewire 103.
Push cannula 187 comprises a distal end 194 and a proximal end 196. A central lumen 199 extends between distal end 194 and proximal end 196. Central lumen 199 accommodates guidewire 103.
System 181 may be used as follows to reduce mitral regurgitation.
First, distal end 115 of guidewire 103 is passed down jugular vein 18 (or the left subclavian vein of a patient, down superior vena cava 9, through right atrium 24 of the heart, and into coronary sinus It will be appreciated that as flexible guidewire 103 is passed down coronary sinus 30, the guidewire will tend to assume the natural curved shape of the coronary sinus, due to the flexible nature of the guidewire. The guidewire's atraumatic spring tip 121 will help minimize damage to vascular structures as the guidewire is advanced into position.
37 Next, distal end 188 of straight, substantially rigid elongated body 184 is placed over proximal end 118 of guidewire 103 and passed a short distance down the guidewire. Then the distal end 194 of push cannula 187 is placed over proximal end 118 of guidewire 103, and then push cannula 187 is advanced down the guidewire. As push cannula 187 is advanced down the guidewire, its distal end 194 pushes the straight, substantially rigid elongated body 184 ahead of it. See Fig. 13.
As the straight, substantially rigid elongated body 184 is passed down the coronary sinus, it will force the coronary sinus to assume a straight configuration at the point where the straight, substantially rigid elongated body 184 currently resides. Push cannula 187 is pushed down guidewire as needed, until the straight, substantially rigid elongated body 184 is located adjacent to the posterior annulus of the mitral valve. As this occurs, the presence of the straight, substantially rigid elongated body 184 in the coronary sinus will 38 cause coronary sinus to assume a substantially straight configuration at this point, so that the posterior annulus of the mitral valve is forced anteriorly. This will cause the posterior mitral valve leaflet to also move anteriorly so as to improve leaflet coaptation and thereby reduce (or completely eliminate) mitral valve regurgitation. Using standard visualization means echocardiography or fluoroscopy), the exact position of the straight, substantially rigid elongated body may be adjusted so as to reduce (or completely eliminate) regurgitation in the mitral valve.
If desired, the push cannula 187 may be provided with a releasably attachable interface a grasper) so that it may releasably secure the proximal end 190 of the straight, substantially rigid elongated body 184. Such a feature will permit the straight, substantially rigid elongated body to be pulled backward within the c ronary sinus, either for positioning or removal purposes.
39 Alternatively, elongated body 184 or 157 may have any of a variety of non-straight shapes along its length. For example, the elongated body may be wavy, spiraled, or curved along all or a portion of its length. By way of example, elongated body 157 and/or 184 may have a curved configuration so as to invert the natural curvatureof the coronary sinus, so that it is bowed towards the anterior annulus. Or the elongated body may haye a compound shape along its length, it may have a sort of shape, with the center of the being directed towards the anterior annulus. Any of these or other alternate shapes may effect the anterior displacement of the posterior annulus that results in reduction of the mitral valve regurgitation.
In other alternative embodiments, the elongated body may be flexible along at least a portion of its length. Regional flexibility and regional stiffness may allow for straightening of select locations of the coronary sinus and corresponding locations of the posterior mitral annulus. This can cause regions of the mitral annulus to move anteriorly, thus causing regional improvements in leaflet coaptation. In addition, the elongated body may be formed by two end segments connected together by a filament: by anchoring the two end'segments relative to the anatomy and pulling the filament taught, the naturally curved wall of the coronary sinus can be straightened, whereby to move the posterior mitral annulus anteriorly and thereby reduce mitral regurgitation.
Throughout this specification and the claims which follow, unless the context requires otherwise, the word "comprise", and variations such as "comprises" and "comprising", will be understood to imply the inclusion of a stated integer or step or group of integers or steps but not the exclusion of any other integer or step or group of integers or steps.
The reference to any prior art in this specification is not, and should not be taken as, an acknowledgement or any form of suggestion that the prior art forms part of the common general knowledge in Australia.

Claims (19)

1. A method for reducing mitral regurgitation 0 comprising: inserting an elongated substantially straight apparatus into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the apparatus having a distal end, a proximal end, and an intermediate portion, and being so configured that the distal and proximal ends apply a posteriorly-directed force g to the posterior wall of the coronary sinus and the intermediate portion applies an anteriorly-directed force to the anterior wall of the coronary sinus, to straighten the natural curvature of at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
2. A method for reducing mitral regurgitation comprising: inserting an elongated substantially straight apparatus into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the apparatus having a distal end, a proximal end, and an intermediate portion, and being so configured that the distal and proximal ends apply a posteriorly-directed force to the posterior wall of the coronary sinus and the intermediate portion applies an anteriorly-directed force to the anterior wall of the coronary sinus, to move at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve anteriorly, whereby to move the posterior annulus anteriorly and thereby improve 42 leaflet coaptation.
3. A method for reducing mitral regurgitation oC 0 comprising: inserting an elongated substantially straight Ch apparatus into the coronary sinus of a patient in the Svicinity of the posterior leaflet of the mitral valve, the C apparatus having a distal end, a proximal end, and an IND intermediate portion, and being so configured that the S 10 distal and proximal ends apply a posteriorly-directed force to the posterior wall of the coronary sinus and the intermediate portion applies an anteriorly-directed force to the anterior wall of the coronary sinus, to reduce the degree of natural curvature of at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
4. A method for reducing mitral regurgitation comprising: inserting an elongated substantially straight apparatus into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the apparatus having a distal end, a proximal end, and an intermediate portion, and being so configured that the distal and proximal ends apply a posteriorly-directed force to the posterior wall of the coronary sinus and the intermediate portion app lies an anteriorly-directed force to the anterior wall of the coronary sinus, to increase the natural radius of curvature of at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, whereby to move the posterior annulus 43 anteriorly and thereby improve leaflet coaptation.
A method for reducing mitral regurgitation 0C comprising: inserting an elongated substantially straight Capparatus into the coronary sinus of a patient in the Svicinity of the posterior leaflet of the mitral valve, the O apparatus having a distal end, a proximal end and an D intermediate portion, the apparatus being configured so that 0 10 when the apparatus is positioned in the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, the distal and proximal ends apply a posteriorly-directed force to the posterior wall of the coronary sinus and the intermediate portion applies an anteriorly-directed force to the anterior wall of the coronary sinus, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
6. A method for reducing mitral regurgitation comprising: inserting a substantially straight elongated body having a distal end, a proximal end, and an intermediate portion into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the length of the substantially straight elongated body being sized relative to the natural curvature of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve so that when the substantially straight elongated body is positioned in the coronary sinus, the body ends apply a posteriorly-directed force to the posterior wall of the coronary sinus and the body intermediate portion applies an anteriorly-directed force to the anterior wall of the 44 coronary sinus, to cause at least a portion of the coronary sinus to assume a substantially straight configuration adjacent to the posterior leaflet of the mitral valve, 0C whereby to increase the radius of curvature of the mitral annulus and thereby improve leaflet coaptation.
7. A method for reducing mitral regurgitation C comprising: IND inserting a substantially rigid and substantially C 10 straight elongated body having a distal end, a proximal end, and an intermediate portion into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the elongated body being configured relative to the natural curvature of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve so that when the elongated body is positioned in the coronary sinus, the body ends apply a posteriorly-directed force to the posterior wall of the coronary sinus and the body intermediate portion applies an anteriorly-directed force to the anterior wall of the coronary sinus, to cause at least a portion of the coronary sinus to assume a different configuration adjacent to the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
8. A method for reducing mitral regurgitation comprising: inserting a substantially straight, substantially rigid elongated body having a distal end, a proximal end, and an intermediate portion into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the length of the elongated body being sized 45 relative to the natural curvature of the coronary sinus in Cthe vicinity of the posterior leaflet of the mitral valve so that when the elongated body is positioned in the coronary sinus, the body ends apply a posteriorly-directed force to the posterior wall of the coronary sinus and the body C intermediate portion applies an anteriorly-directed force to Sthe anterior wall of the coronary sinus, to cause at least a C portion of the coronary sinus to assume a substantially IND straight configuration adjacent to the posterior leaflet of C 10 the mitral valve, whereby to increase the radius of curvature of the mitral annulus and thereby improve leaflet coaptation.
9. A method for reducing mitral regurgitation comprising: inserting an elongated substantially straight apparatus having a distal end, a proximal end and an intermediate portion into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the apparatus being so configured that the apparatus ends apply a posteriorly-directed force to the posterior wall of the coronary sinus and the apparatus intermediate portion applies an anteriorly-directed force to the anterior wall of the coronary sinus, to invert the natural curvature of at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
10. Apparatus for reducing mitral regurgitation comprising: 46 g an elongated substantially straight body having a distal end, a proximal end and an intermediate portion, the body being configured so that when the body is positioned in 0C the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, the distal and proximal ends apply a C posteriorly-directed force to the posterior wall of the Scoronary sinus, and the intermediate portion applies an O anteriorly-directed force to the anterior wall of the IND coronary sinus, whereby to move the posterior annulus of the C 10 mitral valve anteriorly and thereby improve leaflet coaptation.
11. Apparatus according to claim 10 wherein said body is provided with a central lumen extending therethrough, and said apparatus further comprises: a guidewire dimensioned for slidable disposition in the body central lumen; and a cannula for sliding disposition on said guidewire; whereby said body and said cannula are mountable on said guidewire and movement of said cannula on said guidewire in a distal direction pushes said body distally along said guidewire.
12. Apparatus for reducing mitral regurgitation comprising: a substantially straight elongated body having a distal end, a proximal end and an intermediate portion, and adapted to be inserted into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the length of the substantially straight elongated body being sized relative to the natural curvature of the 47 coronary sinus in the vicinity of the posterior leaflet of Cthe mitral valve so that when the substantially straight elongated body is positioned in the coronary sinus, the body 0_ ends apply a posteriorly-directed force to the posterior wall of the coronary sinus and the body intermediate portion C applies an anteriorly-directed force to the anterior wall of Sthe coronary sinus, to cause at least a portion of the Ccoronary sinus to assume a substantially straight IND configuration adjacent to the posterior leaflet of the S 10 mitral valve, whereby to increase the radius of curvature of the mitral annulus, moving it anteriorly, and thereby improve leaflet coaptation.
13. Apparatus for reducing mitral regurgitation comprising: a substantially rigid and substantially straight elongated body having a distal end, a proximal end, and an intermediate portion, and adapted to be inserted into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the length of the elongated body being sized relative to the natural curvature of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve so that when the elongated body is positioned in the coronary sinus, the body applies a posteriorly-directed force to the posterior wall of the coronary sinus and applies an anteriorly-directed force to the anterior wall of the coronary sinus, to cause at least a portion of the coronary sinus to assume a different configuration adjacent to the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation. 48 g
14. Apparatus for reducing mitral regurgitation Scomprising: a substantially straight, substantially rigid 0C elongated body having a distal end, a proximal end, and an intermediate portion, and adapted to be inserted into the C coronary sinus of a patient in the vicinity of the posterior Sleaflet of the mitral valve, the length of the elongated O body being sized relative to the natural curvature of the IND coronary sinus in the vicinity of the posterior leaflet of C 10 the mitral valve so that when the elongated body is positioned in the coronary sinus, the body ends apply a posteriorly-directed force to the posterior wall of the coronary sinus and the body intermediate portion applies an anteriorly-directed force to the anterior wall of the coronary sinus, to cause at least a portion of the coronary sinus to assume a substantially straight configuration adjacent to the posterior leaflet of the mitral valve, whereby to increase the radius of curvature of the mitral annulus, moving it anteriorly, and thereby improve leaflet coaptation.
Apparatus according to claim 14 further comprising a delivery catheter adapted to be positioned within the coronary sinus of the patient, said delivery catheter being formed out of a flexible material so that it will substantially assume the configuration of the coronary sinus, said delivery catheter being adapted to receive said elongated body therein.
16. Apparatus according to claim 15 wherein said elongated body is mounted to a rod, wherein said rod is formed out of a flexible material so that said rod will 49 g assume the configuration of the coronary sinus, and further Swherein said rod is sized to fit within said delivery catheter. 00
17. Apparatus according to claim 15 further comprising C a removable guidewire for positioning said delivery catheter Sin the coronary sinus. D
18. Apparatus according to claim 17 wherein said C 10 guidewire is provided with a spring tip at a distal end thereof.
19. Apparatus according to claim 14 further comprising a guidewire adapted to be positioned within the coronary sinus, said guidewire being formed out of a flexible material so that it will substantially assume the configuration of the coronary sinus, and further wherein the elongated body is cannulated for riding along said guidewire. Apparatus for reducing mitral regurgitation comprising: an elongated substantially straight body having a distal end, a proximal end and an intermediate portion, and adapted to be inserted into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the body being so configured that the body ends apply a posteriorly-directed force to the posterior wall of the coronary sinus and the body intermediate portion applies an anteriorly-directed force to the anterior wall of the coronary sinus, to invert the natural curvature of at least a portion of the coronary sinus in the vicinity of the 4 50 0 c posterior leaflet of the mitral valve, whereby to move the Sposterior annulus anteriorly and thereby improve leaflet Scoaptation. 00 KC/VIA29PCTAUSTRALIADIV. FOR2
AU2006203499A 2001-02-05 2006-08-14 Method and apparatus for improving mitral valve function Ceased AU2006203499B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2006203499A AU2006203499B2 (en) 2001-02-05 2006-08-14 Method and apparatus for improving mitral valve function

Applications Claiming Priority (23)

Application Number Priority Date Filing Date Title
US26676601P 2001-02-05 2001-02-05
US60/266,766 2001-02-05
US27389301P 2001-03-05 2001-03-05
US60/273,893 2001-03-05
US27815301P 2001-03-23 2001-03-23
US60/278,153 2001-03-23
US27997401P 2001-03-29 2001-03-29
US27997301P 2001-03-29 2001-03-29
US60/279,973 2001-03-29
US60/279,974 2001-03-29
US28003801P 2001-03-30 2001-03-30
US60/280,038 2001-03-30
US28382001P 2001-04-13 2001-04-13
US60/283,820 2001-04-13
US31221701P 2001-08-14 2001-08-14
US60/312,217 2001-08-14
US33948101P 2001-10-26 2001-10-26
US60/339,481 2001-10-26
US34842402P 2002-01-14 2002-01-14
US60/348,424 2002-01-14
AU2002240288A AU2002240288B2 (en) 2001-02-05 2002-02-05 Method and apparatus for improving mitral valve function
PCT/US2002/003550 WO2002062408A2 (en) 2001-02-05 2002-02-05 Method and apparatus for improving mitral valve function
AU2006203499A AU2006203499B2 (en) 2001-02-05 2006-08-14 Method and apparatus for improving mitral valve function

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2002240288A Division AU2002240288B2 (en) 2001-02-05 2002-02-05 Method and apparatus for improving mitral valve function

Publications (2)

Publication Number Publication Date
AU2006203499A1 AU2006203499A1 (en) 2006-08-31
AU2006203499B2 true AU2006203499B2 (en) 2009-03-05

Family

ID=40432093

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006203499A Ceased AU2006203499B2 (en) 2001-02-05 2006-08-14 Method and apparatus for improving mitral valve function

Country Status (1)

Country Link
AU (1) AU2006203499B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2962664B1 (en) 2010-07-09 2022-05-11 Highlife SAS Transcatheter atrio-ventricular valve prosthesis

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5332402A (en) * 1992-05-12 1994-07-26 Teitelbaum George P Percutaneously-inserted cardiac valve
US5957949A (en) * 1997-05-01 1999-09-28 World Medical Manufacturing Corp. Percutaneous placement valve stent
US6162245A (en) * 1997-05-07 2000-12-19 Iowa-India Investments Company Limited Stent valve and stent graft
US6187040B1 (en) * 1999-05-03 2001-02-13 John T. M. Wright Mitral and tricuspid annuloplasty rings
US6419696B1 (en) * 2000-07-06 2002-07-16 Paul A. Spence Annuloplasty devices and related heart valve repair methods

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5332402A (en) * 1992-05-12 1994-07-26 Teitelbaum George P Percutaneously-inserted cardiac valve
US5957949A (en) * 1997-05-01 1999-09-28 World Medical Manufacturing Corp. Percutaneous placement valve stent
US6162245A (en) * 1997-05-07 2000-12-19 Iowa-India Investments Company Limited Stent valve and stent graft
US6187040B1 (en) * 1999-05-03 2001-02-13 John T. M. Wright Mitral and tricuspid annuloplasty rings
US6419696B1 (en) * 2000-07-06 2002-07-16 Paul A. Spence Annuloplasty devices and related heart valve repair methods

Also Published As

Publication number Publication date
AU2006203499A1 (en) 2006-08-31

Similar Documents

Publication Publication Date Title
AU2002240288B2 (en) Method and apparatus for improving mitral valve function
US7186264B2 (en) Method and apparatus for improving mitral valve function
US7125420B2 (en) Method and apparatus for improving mitral valve function
AU2002240288A1 (en) Method and apparatus for improving mitral valve function
US7052487B2 (en) Method and apparatus for reducing mitral regurgitation
US6790231B2 (en) Apparatus and method for reducing mitral regurgitation
EP1383448B1 (en) Apparatus for improving mitral valve function
US20030078654A1 (en) Method and apparatus for improving mitral valve function
US6890353B2 (en) Method and apparatus for reducing mitral regurgitation
AU2010200752A1 (en) Method and apparatus for improving mitral valve function
AU2006203499B2 (en) Method and apparatus for improving mitral valve function
WO2003034947A1 (en) Method and apparatus for reducing mitral regurgitation

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired